These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2026891)

  • 1. Empyema caused by Clostridium sordellii, a rare form of pleuropulmonary disease.
    Buchman AL; Ponsillo M; Nagami PH
    J Infect; 1991 Mar; 22(2):171-4. PubMed ID: 2026891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrotizing pneumonia and empyema caused by Bacillus cereus and Clostridium bifermentans.
    Jonsson S; Clarridge J; Young EJ
    Am Rev Respir Dis; 1983 Mar; 127(3):357-9. PubMed ID: 6402966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotizing pneumonia and empyema due to Clostridium perfringens. Report of a case and review of the literature.
    Bayer AS; Nelson SC; Galpin JE; Chow AW; Guze LB
    Am J Med; 1975 Dec; 59(6):851-6. PubMed ID: 171947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Bishara J; Wattad M; Paul M
    Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
    [No Abstract]   [Full Text] [Related]  

  • 5. Pneumonia and empyema caused by Clostridium sordellii.
    File TM; Fass RJ; Perkins RL
    Am J Med Sci; 1977; 274(2):211-2. PubMed ID: 602960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin.
    Wilcox MH; Howe R
    J Antimicrob Chemother; 1995 Oct; 36(4):673-9. PubMed ID: 8591942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ; Murdoch DR
    Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile-associated disease treatment response depends on definition of cure.
    Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
    Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
    [No Abstract]   [Full Text] [Related]  

  • 10. [Approach to the treatment of intestinal infectious diseases caused by Clostridium difficile].
    Nyc O
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):93-6. PubMed ID: 20640987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-lethal Clostridium sordellii bacteraemia in an immunocompromised patient with pleomorphic sarcoma.
    Bonnecaze AK; Stephens SE; Miller PJ
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27489063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Manthey CF; Eckmann L; Fuhrmann V
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1239-1250. PubMed ID: 28766951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous clostridial empyema and pyopneumothorax.
    Raff MJ; Johnson JD; Nagar D; Ferris FZ; McCormick ML
    Rev Infect Dis; 1984; 6(5):715-9. PubMed ID: 6095404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy.
    Tieu JD; Schmidt SA; Miller JL; Kupiec KE; Skrepnek GH; Liu C; Smith WJ
    J Oncol Pharm Pract; 2019 Apr; 25(3):520-528. PubMed ID: 29157145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
    Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
    Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile bacteremia.
    Kaufman E; Liska D; Rubinshteyn V; Nandakumar G
    Surg Infect (Larchmt); 2013 Dec; 14(6):559-60. PubMed ID: 24111758
    [No Abstract]   [Full Text] [Related]  

  • 18. ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease.
    Am J Health Syst Pharm; 1998 Jul; 55(13):1407-11. PubMed ID: 9659970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on "High frequency of nonadherence to Clostridium difficile treatment guidelines".
    Froom P
    South Med J; 2014 Sep; 107(9):600-1. PubMed ID: 25188628
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of metronidazole use on tacrolimus concentrations in transplant patients treated for Clostridium difficile.
    Early CR; Park JM; Dorsch MP; Pogue KT; Hanigan SM
    Transpl Infect Dis; 2016 Oct; 18(5):714-720. PubMed ID: 27501504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.